{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:26:27Z","timestamp":1790065587838,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.rmr.2015.06.017","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T23:41:54Z","timestamp":1454456514000},"page":"102-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Atteinte respiratoire pr\u00e9coce chez les nourrissons atteints de mucoviscidose. Outils de diagnostic et pistes pour la prise en charge"],"prefix":"10.1016","volume":"33","author":[{"given":"P.","family":"Reix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Matecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2015.06.017_bib0005","series-title":"Registre fran\u00e7ais de la mucoviscidose. Bilan des donn\u00e9es 2012. Vaincre la mucoviscidose et INED","year":"2014"},{"key":"10.1016\/j.rmr.2015.06.017_bib0010","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.arcped.2014.03.014","article-title":"Recommandations nationales pour la prise en charge du nourrisson d\u00e9pist\u00e9 atteint de mucoviscidose. Consensus de la f\u00e9d\u00e9ration des centres de ressources et de comp\u00e9tences de la mucoviscidose","volume":"21","author":"Sermet-Gaudelus","year":"2014","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.rmr.2015.06.017_bib0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcf.2010.04.008","article-title":"Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening","volume":"9","author":"Sermet-Gaudelus","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2015.06.017_bib0020","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Borowitz","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2015.06.017_bib0025","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1542\/peds.2007-3089","article-title":"Recovery of birth weight z score within 2\u00a0years of diagnosis is positively associated with pulmonary status at 6\u00a0years of age in children with cystic fibrosis","volume":"123","author":"Lai","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmr.2015.06.017_bib0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1378\/chest.10-1504","article-title":"Relationships among health-related quality of life, pulmonary health, and newborn screening for cystic fibrosis","volume":"140","author":"Tluczek","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2015.06.017_bib0035","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ppul.21279","article-title":"Baseline characteristics and factors associated with nutritional and pulmonary status at enrolment in the cystic fibrosis EPIC observational cohort","volume":"45","author":"Rosenfeld","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2015.06.017_bib0040","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.jpeds.2005.08.034","article-title":"Complications associated with symptomatic diagnosis in infants with cystic fibrosis","volume":"147","author":"Accurso","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2015.06.017_bib0045","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jpeds.2005.08.013","article-title":"The influence of newborn screening for cystic fibrosis on pulmonary outcomes in new South Wales","volume":"147","author":"McKay","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2015.06.017_bib0050","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jpeds.2014.06.061","article-title":"Improvements in lung function and height among cohorts of 6-year-olds with cystic fibrosis from 1994\u00a0to 2012","volume":"165","author":"VanDevanter","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2015.06.017_bib0055","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/archdischild-2011-300449","article-title":"Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre","volume":"96","author":"Dijk","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.rmr.2015.06.017_bib0060","first-page":"91","article-title":"Mucoviscidose\u00a0: malgr\u00e9 les progr\u00e8s, une maladie grave","volume":"61","author":"Bellon","year":"2011","journal-title":"Rev Prat"},{"key":"10.1016\/j.rmr.2015.06.017_bib0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.arcped.2010.10.008","article-title":"Mucoviscidose, les strat\u00e9gies actuelles ne pr\u00e9viennent pas l\u2019atteinte respiratoire\u00a0: il faut intervenir plus t\u00f4t chez les nourrissons d\u00e9pist\u00e9s\u00a0!","volume":"18","author":"Reix","year":"2011","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.rmr.2015.06.017_bib0070","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/rccm.201004-0643OC","article-title":"Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children","volume":"182","author":"Meyerholz","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0075","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1164\/rccm.201307-1268OC","article-title":"Air trapping and airflow obstruction in newborn cystic fibrosis piglets","volume":"188","author":"Adam","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2213-2600(13)70026-2","article-title":"Early lung disease in cystic fibrosis","volume":"1","author":"Grasemann","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1126\/scitranslmed.3000928","article-title":"Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth","volume":"2","author":"Stoltz","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0090","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1073\/pnas.1323633111","article-title":"Assessing mucociliary transport of single particles in vivo shows variable speed and preference for the ventral trachea in newborn pigs","volume":"111","author":"Hoegger","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rmr.2015.06.017_bib0095","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1255825","article-title":"Cystic fibrosis. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis","volume":"345","author":"Hoegger","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.rmr.2015.06.017_bib0100","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1067\/mai.2001.118516","article-title":"Distinct pattern of immune cell population in the lung of human fetuses with cystic fibrosis","volume":"108","author":"Hubeau","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2015.06.017_bib0105","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcf.2006.12.001","article-title":"Early inflammation in the airways of a cystic fibrosis foetus","volume":"6","author":"Verhaeghe","year":"2007","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2015.06.017_bib0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ppul.21154","article-title":"Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?","volume":"45","author":"Tiddens","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2015.06.017_bib0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1513\/AnnalsATS.201312-444LD","article-title":"Cystic fibrosis: NHLBI workshop on the primary prevention of chronic lung diseases","volume":"11","author":"Pittman","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmr.2015.06.017_bib0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0761-8425(08)71583-3","article-title":"EFR du nourrisson\u00a0: le point sur les valeurs normales","volume":"25","author":"Amsallem","year":"2008","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2015.06.017_bib0125","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1164\/rccm.200804-551OC","article-title":"Lung function in infants with cystic fibrosis diagnosed by newborn screening","volume":"178","author":"Linnane","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0130","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/thoraxjnl-2012-201747","article-title":"Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening","volume":"67","author":"Hoo","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2015.06.017_bib0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.201011-1892OC","article-title":"Infection, inflammation, and lung function decline in infants with cystic fibrosis","volume":"184","author":"Pillarisetti","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0140","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/thoraxjnl-2013-204023","article-title":"Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants","volume":"69","author":"Nguyen","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2015.06.017_bib0145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.prrv.2005.09.009","article-title":"Inert gas washout in preschool children","volume":"6","author":"Gustafsson","year":"2005","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.rmr.2015.06.017_bib0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1513\/pats.200611-174HT","article-title":"Imaging and clinical trials in cystic fibrosis","volume":"4","author":"Tiddens","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.rmr.2015.06.017_bib0155","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2015.06.017_bib0160","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","article-title":"Risk factors for bronchiectasis in children with cystic fibrosis","volume":"368","author":"Sly","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0165","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/thoraxjnl-2011-200912","article-title":"Progression of early structural lung disease in young children with cystic fibrosis assessed using CT","volume":"67","author":"Mott","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2015.06.017_bib0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.rti.0000203937.82276.ce","article-title":"Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis","volume":"21","author":"Brody","year":"2006","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.rmr.2015.06.017_bib0175","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/thoraxjnl-2013-204176","article-title":"Is chest CT useful in newborn screened infants with cystic fibrosis at 1\u00a0year of age?","volume":"69","author":"Thia","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2015.06.017_bib0180","first-page":"A295","article-title":"PRAGMA: further support for use as a quantitative CT outcome measure","volume":"38","author":"Rosenow","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2015.06.017_bib0185","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1164\/rccm.201311-2099CI","article-title":"Monitoring cystic fibrosis lung disease by computed tomography. Radiation risk in perspective","volume":"189","author":"Kuo","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1148\/radiol.2532090306","article-title":"Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease?","volume":"253","author":"Loeve","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.rmr.2015.06.017_bib0195","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1148\/radiol.10100278","article-title":"Development of low-dose protocols for thin-section CT assessment of cystic fibrosis in pediatric patients","volume":"257","author":"O\u2019Connor","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.rmr.2015.06.017_bib0200","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcf.2013.09.003","article-title":"HRCT and MRI of the lung in children with cystic fibrosis: comparison of different scoring systems","volume":"13","author":"Sileo","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2015.06.017_bib0205","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1164\/rccm.201309-1659OC","article-title":"Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease","volume":"189","author":"Wielputz","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1148\/radiol.09090039","article-title":"Hyperpolarized 3He MR for sensitive imaging of ventilation function and treatment efficiency in young cystic fibrosis patients with normal lung function","volume":"255","author":"Bannier","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.rmr.2015.06.017_bib0215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1164\/rccm.200901-0069OC","article-title":"Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening","volume":"180","author":"Sly","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0220","first-page":"163","article-title":"Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial","volume":"306","author":"Wainwright","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2015.06.017_bib0225","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ppul.22894","article-title":"Early childhood wheezing is associated with lower lung function in cystic fibrosis","volume":"49","author":"Ren","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2015.06.017_bib0230","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1164\/rccm.2202041","article-title":"Relative ability of full and partial forced expiratory maneuvers to identify diminished airway function in infants with cystic fibrosis","volume":"166","author":"Ranganathan","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1164\/rccm.200710-1599OC","article-title":"Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis","volume":"178","author":"Kozlowska","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0240","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1542\/peds.2007-3139","article-title":"Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study","volume":"122","author":"van Ewijk","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmr.2015.06.017_bib0245","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcf.2013.07.006","article-title":"Pulmonary exacerbations in CF patients with early lung disease","volume":"13","author":"Anstead","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2015.06.017_bib0255","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/thoraxjnl-2012-202342","article-title":"Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5\u00a0years of age","volume":"68","author":"Byrnes","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2015.06.017_bib0260","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.00108212","article-title":"Early intervention studies in infants and preschool children with cystic fibrosis: are we ready?","volume":"42","author":"Stick","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2015.06.017_bib0265","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jcf.2012.09.001","article-title":"Positive parental attitudes to participating in research involving newborn screened infants with CF","volume":"12","author":"Chudleigh","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2015.06.017_bib0270","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.revmed.2013.11.003","article-title":"Actualit\u00e9 th\u00e9rapeutique dans la mucoviscidose","volume":"35","author":"Durupt","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.rmr.2015.06.017_bib0275","first-page":"A286","article-title":"An open-label study of the safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2\u00a0to 5\u00a0years with CF and a CFTR gating mutation: the kiwi study","volume":"38","author":"Davies","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2015.06.017_bib0280","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.rmr.2015.06.017_bib0285","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1542\/peds.2014-1666","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus, infection","volume":"134","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmr.2015.06.017_bib0290","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/jama.2012.5214","article-title":"Inhaled hypertonic saline in infants and children younger than 6\u00a0years with cystic fibrosis: the ISIS randomized controlled trial","volume":"307","author":"Rosenfeld","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2015.06.017_bib0295","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1164\/rccm.201302-0219OC","article-title":"Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline","volume":"188","author":"Subbarao","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0300","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1569-1993(03)00090-0","article-title":"DNase in stable cystic fibrosis infants: a pilot study","volume":"2","author":"Berge","year":"2003","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2015.06.017_bib0305","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ppul.1061","article-title":"Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5\u00a0years: a preliminary study","volume":"31","author":"Nasr","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2015.06.017_bib0310","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2015.06.017_bib0315","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201301-0153OC","article-title":"Efficacy and safety of ivacaftor in patients aged 6\u00a0to 11\u00a0years with cystic fibrosis with a G551D mutation","volume":"187","author":"Davies","year":"2013","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842515011080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842515011080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T19:58:13Z","timestamp":1537041493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842515011080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0761842515011080"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2015.06.017","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atteinte respiratoire pr\u00e9coce chez les nourrissons atteints de mucoviscidose. Outils de diagnostic et pistes pour la prise en charge","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2015.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 SPLF. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}